The active ingredient in Rhinitis Spray is ectoine, a molecule that helps stabilize membranes. This molecule can be used alone or in combination with decongestant nasal sprays to effectively relieve nasal congestion. This treatment is considered safe and effective in treating acute rhinosinusitis.

Rhinitis Spray was tested in a clinical trial in patients with acute rhinosinusitis. The efficacy and tolerability of the spray were evaluated and compared to other drugs used to treat acute rhinosinusitis. Patients and physicians also assessed the safety and effectiveness of the treatment.

A nasal spray mist, contains Fluticasone, which is a corticosteroid. Corticosteroids are effective in treating inflammation and irritation of the nose. The spray also provides relief from a runny, stuffy nose, and sneezing symptoms. Used to treat seasonal and perennial allergic rhinitis.

Rhinitis Spray's effectiveness is evaluated by rhinoscopic analysis. In this study, it showed significantly better tolerability than nasal spray. Despite the side effects, the spray was considered safe and effective for treating acute rhinosinusitis.

The usual dosage for pediatric patients aged four and up is one spray per nostril once a day. This dosage may be increased to twice daily in some cases. But never exceed the recommended dosage. If your child is not responding to the first dose, reduce the dose to one spray in each nostril. It can take up to a week for the nasal spray to work.

HH3A2257